BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19730268)

  • 1. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo.
    Van Rie A; Dow A; Mupuala A; Stewart P
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):636-42. PubMed ID: 19730268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.
    Van Rie A; Mupuala A; Dow A
    Pediatrics; 2008 Jul; 122(1):e123-8. PubMed ID: 18595957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.
    Le Doaré K; Bland R; Newell ML
    Pediatrics; 2012 Nov; 130(5):e1326-44. PubMed ID: 23118140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo.
    Bailey RC; Kamenga MC; Nsuami MJ; Nieburg P; St Louis ME
    Int J Epidemiol; 1999 Jun; 28(3):532-40. PubMed ID: 10405861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo.
    Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Nku D; Napravnik S; Cole SR; Van Rie A; Behets F
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):90-8. PubMed ID: 22732464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.
    Lindsey JC; Malee KM; Brouwers P; Hughes MD;
    Pediatrics; 2007 Mar; 119(3):e681-93. PubMed ID: 17296781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.
    Ditekemena J; Luhata C; Bonane W; Kiumbu M; Tshefu A; Colebunders R; Koole O
    PLoS One; 2014; 9(12):e113877. PubMed ID: 25541707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcomes in HIV-infected and uninfected African children.
    Debeaudrap P; Bodeau-Livinec F; Pasquier E; Germanaud D; Ndiang ST; Nlend AN; Ndongo FA; Guemkam G; Penda CI; Warszawski J; Koecher D; Faye A; Tejiokem MC;
    AIDS; 2018 Nov; 32(18):2749-2757. PubMed ID: 30289800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.
    Kerr SJ; Puthanakit T; Vibol U; Aurpibul L; Vonthanak S; Kosalaraksa P; Kanjanavanit S; Hansudewechakul R; Wongsawat J; Luesomboon W; Ratanadilok K; Prasitsuebsai W; Pruksakaew K; van der Lugt J; Paul R; Ananworanich J; Valcour V;
    AIDS Care; 2014; 26(11):1327-35. PubMed ID: 24878112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.
    Boivin MJ; Green SD; Davies AG; Giordani B; Mokili JK; Cutting WA
    Health Psychol; 1995 Jan; 14(1):13-21. PubMed ID: 7737068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection among children and adolescents in Burundi, Cameroon, and the Democratic Republic of Congo.
    Napierala Mavedzenge S; Newman JE; Nduwimana M; Bukuru H; Kariyo P; Niyongabo T; Mbaya M; Mukumbi H; Kamgaing N; Obama MT; Akam W; Atibu J; Kiumbu M; Hemingway-Foday J
    AIDS Care; 2017 Aug; 29(8):1026-1033. PubMed ID: 28064538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High drug resistance levels could compromise the control of HIV infection in paediatric and adolescent population in Kinshasa, the Democratic Republic of Congo.
    Rubio-Garrido M; Reina G; Ndarabu A; Rodriguez-Galet A; Valadés-Alcaraz A; Barquín D; Carlos S; Holguín Á
    PLoS One; 2021; 16(4):e0248835. PubMed ID: 33857166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.
    Yotebieng M; Edmonds A; Lelo P; Wenzi LK; Ndjibu PT; Lusiama J; Kabuayi JP; Behets F
    AIDS; 2015 Sep; 29(15):2055-7. PubMed ID: 26352882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.
    Lowick S; Sawry S; Meyers T
    Psychol Health Med; 2012; 17(5):599-610. PubMed ID: 22313239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children.
    Bagenda D; Nassali A; Kalyesubula I; Sherman B; Drotar D; Boivin MJ; Olness K
    Pediatrics; 2006 Mar; 117(3):729-40. PubMed ID: 16510653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.
    Edmonds A; Yotebieng M; Lusiama J; Matumona Y; Kitetele F; Napravnik S; Cole SR; Van Rie A; Behets F
    PLoS Med; 2011 Jun; 8(6):e1001044. PubMed ID: 21695087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.